Publications by authors named "Julien Mazières"

100Publications

Bronchoscopic treatment of endobronchial inflammatory myofibroblastic tumors.

Ann Thorac Surg 2020 Jul 13. Epub 2020 Jul 13.

Pulmonology Department, Larrey University Hospital, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2020.05.092DOI Listing
July 2020

Tepotinib in Non-Small-Cell Lung Cancer with Exon 14 Skipping Mutations.

N Engl J Med 2020 09 29;383(10):931-943. Epub 2020 May 29.

From Memorial Sloan Kettering Cancer Center, New York (P.K.P.); the Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (E.F.), and Dr. Rosell Oncology Institute, Dexeus University Hospital, Quirónsalud Group (S.V.), Barcelona; Centre Hospitaliere Universitaire (CHU) Bordeaux, Service des Maladies Respiratoires, Bordeaux (R.V.), Université de Lille, CHU Lille, Thoracic Oncology Department, Centre National de la Recherche Scientifique, INSERM, Institut Pasteur de Lille, UMR9020-UMR-S 1277-Canther, Lille (A.B.C.), CHU de Toulouse, Institut Universitaire du Cancer de Toulouse, Université Paul Sabatier, Toulouse (J.M.), and Institut de Cancérologie de l'Ouest Rene Gauducheau Centre, Saint-Herblain (H. Senellart) - all in France; Saitama Cancer Center, Saitama (H. Sakai), and the Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama (T.K.) - both in Japan; the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.), and the Department of Surgery, Oncology and Gastroenterology, University of Padua and Oncologia Medica 2, Istituto Oncologico Veneto, IRCCS, Padua (P.C.) - both in Italy; Antwerp University Hospital, Edegem, Belgium (J.V.M., J.R.); Asklepios Lung Clinic, Munich-Gauting (N.R.), Pius Hospital Oldenburg, University Medicine Oldenburg, Oldenburg (F.G.), Translational Medicine, Department of Bioinformatics (D.J.), Translational Innovation Platform, Oncology (C.S.), the Department of Biostatistics (R.B.), Translational Medicine, Department of Clinical Biomarkers and Companion Diagnostics (J. Straub), and Global Clinical Development (A.J., J. Scheele), Merck, Darmstadt - all in Germany; the Department of Lung Cancer and Thoracic Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (D.K.); Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), the Center for Lung Cancer, National Cancer Center, Goyang (J.-Y.H.), and Chonnam National University Medical School and Hwasun Hospital, Hwasun (Y.-C.K.) - all in South Korea; Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (J.D.P.); the Department of Medicine, Vanderbilt Ingram Cancer Center, Nashville (L.H.); the Faculty of Medicine, School of Medicine, National Yang-Ming University (G.-C.C.), the Division of Chest Medicine, Department of Internal Medicine, Tri-service General Hospital, National Defense Medical Center (C.-L.T.), National Taiwan University Hospital (J.C.-H.Y.), and the Department of Chest Medicine, Taipei Veterans General Hospital, and School of Medicine, National Yang-Ming University (Y.-M.C.), Taipei, and the Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung (G.-C.C.) - both in Taiwan; the Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam (E.F.S.), and the Department of Pulmonology, University of Groningen and University Medical Center Groningen, Groningen (A.J.W.) - both in the Netherlands; and M.D. Anderson Cancer Center, University of Texas, Houston (J.V.H., X.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa2004407DOI Listing
September 2020

[Finding mutations of interest in circulating tumor DNA helps predict immunotherapy response in lung cancer].

Med Sci (Paris) 2020 May 26;36(5):437-439. Epub 2020 May 26.

Unité d'oncologie thoracique, Hôpital Larrey, CHU Toulouse, Chemin de Pouvourville, 31059 Toulouse Cedex, France. - Inserm, Centre de recherche en cancérologie de Toulouse, CRCT UMR-1037, 31000 Toulouse, France. - Université Paul Sabatier, 31000 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/2020068DOI Listing
May 2020

Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.

Eur Respir Rev 2020 Mar 12;29(155). Epub 2020 Feb 12.

Thoracic Oncology Dept, Hôpital Larrey, University Hospital of Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/16000617.0052-2019DOI Listing
March 2020

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.

J Thorac Oncol 2020 May 25;15(5):860-866. Epub 2020 Jan 25.

Department of Thoracic Oncology, AP-HP, Groupe Hospitalier HUPC, Hôpital Cochin, Paris, France; Centre de Recherche des Cordeliers, Université Paris Descartes, Complement, Inflammation and Cancer, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2020.01.014DOI Listing
May 2020

Management of pulmonary toxicity associated with immune checkpoint inhibitors.

Eur Respir Rev 2019 Dec 6;28(154). Epub 2019 Nov 6.

Respiratory Disease Dept, Larrey Hospital, University Hospital of Toulouse, Paul Sabatier University, Toulouse, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/16000617.0012-2019DOI Listing
December 2019

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.

Lung Cancer 2019 11 6;137:1-6. Epub 2019 Sep 6.

Thoracic Oncology Department, Larrey Hospital, University Hospital of Toulouse, France; Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France; Toulouse Paul Sabatier University, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.09.005DOI Listing
November 2019

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.

Eur J Cancer 2019 07 13;116:182-189. Epub 2019 Jun 13.

Department of Medical Oncology, Gustave Roussy Cancer Campus, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.019DOI Listing
July 2019

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial.

Clin Cancer Res 2019 10 7;25(19):5759-5765. Epub 2019 Jun 7.

Department of Thoracic Oncology, Centre d'investigation clinique Institut national de la santé et de la recherche médicale 1425, Hospital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris-Diderot University (Paris 7), Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2860DOI Listing
October 2019

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Curr Treat Options Oncol 2019 06 6;20(7):60. Epub 2019 Jun 6.

Pulmonology Department, Toulouse University Hospital, Université Paul Sabatier, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-019-0652-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554237PMC
June 2019

Incidence of thyroid dysfunctions during treatment with nivolumab for non-small cell lung cancer: Retrospective study of 105 patients.

Presse Med 2019 Apr 17;48(4):e199-e207. Epub 2019 Apr 17.

CHU Larrey, Department of endocrinology and metabolic diseases, 31059 Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2018.10.019DOI Listing
April 2019

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.

J Thorac Oncol 2019 07 15;14(7):1204-1212. Epub 2019 Apr 15.

Université Côte d'Azur, University Hospital Federation OncoAge, Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France; Université Côte d'Azur, CNRS, INSERM, Institute of Research on Cancer and Ageing of Nice (IRCAN), University Hospital Federation OncoAge, Nice, France; Université Côte d'Azur, University Hospital Federation OncoAge, Hospital-Related Biobank (BB-0033-00025), Pasteur Hospital, Nice, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.03.024DOI Listing
July 2019

Treatment of complex airway stenoses using patient-specific 3D-engineered stents: a proof-of-concept study.

Thorax 2019 08 3;74(8):810-813. Epub 2019 Apr 3.

Service de Pneumologie, Pôle des Voies Respiratoires, CHU Toulouse, Hôpital Larrey, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2018-212732DOI Listing
August 2019

Ultra-sensitive Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring Mutations and Treated with First-generation TKIs.

Clin Cancer Res 2019 07 1;25(14):4280-4289. Epub 2019 Apr 1.

Département de Pathologie et Oncobiologie, Laboratoire de Biologie des Tumeurs Solides, CHU Montpellier, Univ. Montpellier, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2683DOI Listing
July 2019

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).

J Thorac Oncol 2019 06 6;14(6):1095-1101. Epub 2019 Feb 6.

Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.01.011DOI Listing
June 2019

Thoracic Air-Leak Syndrome Complicating Allogeneic Hematopoietic Stem-Cell Transplantation.

Lung 2019 02 29;197(1):101-103. Epub 2018 Oct 29.

Pôle des Voies Respiratoires, Hôpital Larrey, CHU de Toulouse, 31059, Toulouse Cedex 09, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00408-018-0173-z
Publisher Site
http://dx.doi.org/10.1007/s00408-018-0173-zDOI Listing
February 2019

Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.

N Engl J Med 2018 11 25;379(21):2040-2051. Epub 2018 Sep 25.

From Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid (L.P.-A.), and Hospital Universitario Virgen Macarena, Seville (D.V.) - both in Spain; Leningrad Regional Clinical Hospital, St. Petersburg, Russia (A.L.); Wollongong Oncology and Wollongong Private Hospital, Wollongong, NSW, Australia (A.T.); Istanbul Medeniyet University Hospital, Istanbul (M.G.), and Ankara University, Ankara (F.Ç.Ş.) - both in Turkey; Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France (J.M.); Universitätsklinikum Tübingen, Tübingen, Germany (B. Hermes); Jász-Nagykun-Szolnok County Hospital, Szolnok (T.C.), and Országos Korányi TBC és Pulmonológiai Intézet, Budapest (A.F.) - both in Hungary; Oncology Center, Medica Sur Hospital, Mexico City (J.R.-C.); Humber River Regional Hospital, Toronto (J.W.); Sendai Kousei Hospital, Sendai (S.S.), and the Kanagawa Cancer Center, Yokohama (T.K.) - both in Japan; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju, South Korea (K.H.L.); Jilin Cancer Hospital, Changchun, China (Y.C.); University of Turin, Orbassano, Italy (S.N.); Montefiore Medical Center-Albert Einstein College of Medicine, New York (B. Halmos); Merck, Kenilworth, NJ (X.L., G.M.L., B.P.); and the Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland (D.M.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1810865DOI Listing
November 2018

A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics.

J Thorac Oncol 2019 01 11;14(1):130-134. Epub 2018 Sep 11.

Thoracic Oncology unit, PTV, CHU Grenoble CS10217-38043 Grenoble cedex 9, France et INSERM U 823. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.08.2028DOI Listing
January 2019

c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas.

J Thorac Oncol 2018 12 24;13(12):1962-1967. Epub 2018 Aug 24.

Sorbonne University, GRC n°04, Theranoscan, F-75252, Paris, France; AP-HP, GH HUEP, Tenon Hospital, Chest Department and Thoracic Oncology, F-75970, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183096
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.08.008DOI Listing
December 2018

Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit.

Support Care Cancer 2019 May 17;27(5):1679-1686. Epub 2018 Aug 17.

Thoracic Oncology Department, Larrey Hospital, University Hospital Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4415-7DOI Listing
May 2019

Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.

Lung Cancer 2018 07 26;121:70-75. Epub 2018 May 26.

Université Côte d'Azur, CNRS UMR7284, INSERM U1081, IRCAN Team 4, FHU OncoAge, Nice, France; Université Côte d'Azur, CHU Nice, FHU OncoAge, Laboratory of Clinical and Experimental Pathology, Nice, France; Université Côte d'Azur, CHU Nice, FHU OncoAge, Hospital-Integrated Biobank (BB-0033-00025), Nice, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.05.009DOI Listing
July 2018

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.

Lung Cancer 2018 06 3;120:108-112. Epub 2018 Apr 3.

Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France; Laboratoire de Biologie Médicale Oncologique, Institut Universitaire du Cancer de Toulouse, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183031
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.04.001DOI Listing
June 2018

Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab Treatment.

Eur Thyroid J 2018 Mar 4;7(2):84-87. Epub 2018 Jan 4.

Department of Endocrinology and Metabolic Diseases, Larrey University Hospital, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000485742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869363PMC
March 2018

Integration of 3D printing and additive manufacturing in the interventional pulmonologist's toolbox.

Respir Med 2018 01 2;134:139-142. Epub 2017 Dec 2.

Service de Pneumologie, Hôpital Larrey, 24 chemin de Pouvourville, 31059 Toulouse Cedex 9, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2017.11.019DOI Listing
January 2018

[The Ras-related GTPase RhoB, a relevant actor in the adaptive resistance to EGFR tyrosine kinase inhibitors in lung cancers].

Med Sci (Paris) 2018 Jan 31;34(1):12-14. Epub 2018 Jan 31.

Inserm U1037, centre de recherches en cancérologie de Toulouse, université Paul Sabatier, F-31057, Toulouse, France - Institut Claudius Regaud, Institut universitaire du cancer-oncopole, F-31057, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20183401003DOI Listing
January 2018

Concerns About Lung Cancer Among Prisoners.

Lung 2018 02 3;196(1):115-124. Epub 2018 Jan 3.

Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique, Centre Hospitalier Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon, 165 chemin du grand Revoyet, 69310, Pierre Bénite, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00408-017-0066-6
Publisher Site
http://dx.doi.org/10.1007/s00408-017-0066-6DOI Listing
February 2018

Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.

Clin Lung Cancer 2018 05 21;19(3):e277-e285. Epub 2017 Nov 21.

Department of Radiation Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France; Université Paul Sabatier, Toulouse, France; INSERM U1037, Centre de Recherche Contre le Cancer de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.11.002DOI Listing
May 2018

Endobronchial Protrusion of an Amplatzer Plug After Embolization of the Pulmonary Artery.

J Bronchology Interv Pulmonol 2017 07;24(3):33-34

*Department of Pulmonology †Department of Radiology, Toulouse University Hospital, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LBR.0000000000000376DOI Listing
July 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

Molecular biomarkers for lung adenocarcinoma.

Eur Respir J 2017 04 5;49(4). Epub 2017 Apr 5.

Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01734-2016DOI Listing
April 2017

Stenting of Complex Malignant Central-Airway Obstruction Guided by a Three-Dimensional Printed Model Of The Airways.

Ann Thorac Surg 2017 Apr;103(4):e357-e359

Service de Pneumologie-Allergologie, Hôpital Larrey - CHU de Toulouse, Université de Toulouse III (Paul Sabatier), Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2016.09.082DOI Listing
April 2017

Techniques of endoscopic airway tumor treatment.

J Thorac Dis 2016 Nov;8(11):3343-3360

Pulmonology Department, Larrey University Hospital, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2016.11.49DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179419PMC
November 2016

Acute interstitial nephritis related to immune checkpoint inhibitors.

Br J Cancer 2016 Dec 10;115(12):1457-1461. Epub 2016 Nov 10.

Département de Néphrologie et Transplantation d'organes, Centre de référence des maladies rénales rares, Hôpital Rangueil, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155358PMC
December 2016

Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer.

Acta Derm Venereol 2017 04;97(4):539-540

Pulmonary Medicine Unit, Hôpital Larrey, Centre Hospitalier Universitaire Toulouse, , Université de Toulouse III,, 31 000 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-2566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545893PMC
April 2017

Erratum to "Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network" [Lung Cancer, 97 (July 2016), 99-104].

Lung Cancer 2016 11 6;101:146. Epub 2016 Oct 6.

Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.014DOI Listing
November 2016

Bronchoscopic Multimodal Management of Tracheal Neurofibroma.

J Bronchology Interv Pulmonol 2016 Oct;23(4):340-342

*Service de Pneumologie-Allergologie, Hôpital Larrey - CHU de Toulouse, Université de Toulouse III (Paul Sabatier) †Institut Universitaire du Cancer Toulouse Oncopole, Avenue Hubert Curien, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LBR.0000000000000220DOI Listing
October 2016

Routine molecular profiling of patients with NSCLC - Authors' reply.

Lancet 2016 09;388(10049):1054-1055

Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille Cedex 20, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)31136-9DOI Listing
September 2016

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.

Lung Cancer 2016 10 22;100:1-4. Epub 2016 Jul 22.

Thoracic Oncology Department, Larrey Hospital, University Hospital of Toulouse, France; Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France; University of Toulouse III (Paul Sabatier), Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.07.021DOI Listing
October 2016

Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network.

Lung Cancer 2016 07 3;97:99-104. Epub 2016 May 3.

Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.04.024DOI Listing
July 2016

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.

J Thorac Oncol 2016 09 7;11(9):e109-12. Epub 2016 May 7.

Thoracic Oncology Department, Larrey Hospital, University Hospital of Toulouse, University of Toulouse III (Paul Sabatier), Toulouse, France; Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864163040
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2016.05.001DOI Listing
September 2016

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies.

Curr Opin Oncol 2016 07;28(4):254-63

aDepartment of Medical Oncology and Clinical Research bDepartment of Oncodermatology cDepartment of Pathology dDepartment of Oral Medicine, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole eDepartment of Oncopneumology, Hopital Larrey, Toulouse University, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000290DOI Listing
July 2016

Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung.

Clin Lung Cancer 2016 09 17;17(5):391-397. Epub 2016 Mar 17.

Pulmonary Medicine Unit, Hôpital Larrey, Centre Hospitalier Universitaire Toulouse, Université de Toulouse III, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.03.001DOI Listing
September 2016

Tracheal Glomangioleiomyoma Treated by Multimodal Interventional Bronchoscopy.

Ann Thorac Surg 2016 Apr;101(4):1591-4

Service de Pneumologie-Allergologie, Hôpital Larrey - CHU de Toulouse, Université de Toulouse III (Paul Sabatier), Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2015.05.128DOI Listing
April 2016